Impact of Rechallenge with Imatinib in Patients with Advanced Gastrointestinal Stromal Tumor after Failure of Imatinib and Sunitinib

Table 3

Adverse events.

Toxicities	Grade 1		Grade 2		Grade 3/4
	IM + BSC	BSC	IM + BSC	BSC	IM + BSC	BSC
Anemia	2	3	0	2	0	0
Leukopenia	2	1	4	0	0	0
Neutropenia	3	0	0	0	0	0
Thrombocytopenia	2	1	1	0	0	0
Liver dysfunction	1	3	1	1	0	0
Skin rash	1	0	0	0	0	0
Edema	12	4	1	0	0	0
Nausea	3	2	1	0	0	0
Anorexia	3	2	0	0	0	0
Diarrhea	3	2	0	0	0	0

IM: imatinib; BSC: best supportive care.